OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Orthofix Medical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$9.59+0.21 (+2.24%)
Close on Oct 19, 2026
- Market cap
- $392.29M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.47 (−36.32%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Orthofix Medical Inc. grew revenue 3.0% to $833.19M over the twelve months to Jun 30, 2026. Free cash flow was -$27.82M, down 6135.6% from a year earlier.
Revenue
$833.19M
+3.0% vs. a year earlier
Operating income
-$39.12M
TTM Q2 2026
Free cash flow
-$27.82M
-6135.6% vs. a year earlier
EPS, diluted
-$1.54
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $392.29M
- P/E ratio
- –
- Price to sales
- 0.47
- Price to book
- 0.91
- Dividend yield
- –
- Free cash flow yield
- -7.09%
Fundamentals
- Revenue
- $833.19M
- Net income
- -$61.72M
- EPS, diluted
- -$1.54
- Free cash flow
- -$27.82M
- Book value per share
- $10.49
- Diluted shares
- 41M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$833.19M+3.0% YoY
Gross profit
$594.12M+9.0% YoY
Operating income
-$39.12M
Net income
-$61.72M
EPS, diluted
-$1.54
Free cash flow
-$27.82M-6135.6% YoY
Reported periodTrailing twelve months